Cube Labs S.P.A. (IT:CUBE) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cube Labs’ subsidiary, Adamas Biotech, has secured official registration from Italy’s Ministry of Health for Theakine® Prost, a green tea-based supplement aimed at improving prostate health. The company plans to partner with firms in the urology sector for its distribution, rather than marketing it directly. This development signifies a strategic advancement in Cube Labs’ commercial endeavors within the healthcare sector.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.